Penn State University
Kristina Petersen PhD, APD, FAHA
A randomized, 2-arm, parallel trial will be conducted to examine the effect of pecans on markers of peripheral vascular health, lipids and lipoproteins, blood pressure, and glycemic control.
Cardiovascular Diseases
Pecans
Usual Care
Phase 2
A randomized, 2-arm, parallel trial will be conducted to examine the effect of including 2 oz./day of pecans, as a snack, compared to a diet typically consumed by participants intake (devoid of nuts) on markers of peripheral vascular health, lipids and lipoproteins, blood pressure, and glycemic control. Participants will be randomized to pecans or control for 12-weeks. Outcome assessments will be measured at baseline and 12-weeks.}}
Study Type : | Interventional |
Estimated Enrollment : | 138 participants |
Masking : | Double |
Primary Purpose : | Prevention |
Official Title : | Cardiometabolic Effects of Including Pecans as a Snack to Improve Diet Quality: a Randomized Controlled Study |
Actual Study Start Date : | August 15, 2022 |
Estimated Primary Completion Date : | March 1, 2024 |
Estimated Study Completion Date : | March 1, 2024 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Pecan Group Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack |
Drug: Pecans |
Active Comparator: Usual Care Group Participants will consume their usual diet devoid of nuts |
Other: Usual Care |
Ages Eligible for Study: | 25 Years to 70 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Penn State University
University Park, Pennsylvania, United States, 16802